Improved Anti-Triple Negative Breast Cancer Effects of Docetaxel by RGD-Modified Lipid-Core Micelles

Overview of attention for article published in International Journal of Nanomedicine, August 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 24 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 18 publications that cite this research output.

18

The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.

αvβ3 integrin targeting RGD peptide-based nanoparticles as an effective strategy for selective drug delivery to tumor microenvironment

Article in Journal of Drug Delivery Science and Technology (June 2024)

Docetaxel-loaded nanoformulations delivery for breast cancer management: Challenges, recent advances, and future perspectives

Article in Journal of Drug Delivery Science and Technology (February 2024)

RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin–RGD interactions

Article in Cancer Medicine (January 2024)